However, as patients with SLE often present functional autoantibodies against EPO or EPOR that associate with faster disease progression (20–23), we speculate that impaired EPO production or signaling further unleashes the autoimmune response in affected individuals. This evidence concerns the gene EPO and systemic lupus erythematosus.